Bioequivalence Study of Empagliflozin And Linagliptin Tablets in Healthy Chinese Subjects
Condition(s):HealthyLast Updated:July 21, 2023Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:July 21, 2023Completed
Condition(s):Type 2 Diabetes Mellitus; Mild Cognitive ImpairmentLast Updated:March 21, 2024Recruiting
Condition(s):Diabetes Mellitus Type 2Last Updated:July 29, 2019Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:February 23, 2024Completed
Condition(s):Type2 DiabetesLast Updated:January 14, 2022Unknown status
Condition(s):Diabetes Mellitus, Type 2Last Updated:February 15, 2019Completed
Condition(s):Type 2 Diabetes; Urinary Tract InfectionsLast Updated:February 2, 2021Unknown status
Condition(s):Diabetes Mellitus, Type 2Last Updated:July 11, 2016Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:February 24, 2016Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:April 4, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.